{"id":904626,"date":"2025-11-03T18:19:56","date_gmt":"2025-11-03T23:19:56","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/"},"modified":"2025-11-03T18:19:56","modified_gmt":"2025-11-03T23:19:56","slug":"bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/","title":{"rendered":"BBOT to Participate in the Jefferies Global Healthcare Conference in London"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SOUTH SAN FRANCISCO, Calif., Nov.  03, 2025  (GLOBE NEWSWIRE) &#8212; BridgeBio Oncology Therapeutics, Inc. (\u201cBBOT\u201d) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in a presentation at the Jefferies Global Healthcare Conference on Monday, November 17, at 2:30 p.m. GMT.\u00a0\u00a0<\/p>\n<p align=\"left\">A live webcast of the presentation will be accessible on the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=l0V4WuAyuDCEMApyTSEtpKqpLcDeW3cPMkZqxYILeuIOg2MhTdfVTwegYrZCQTUwvyvqRa3Lk5avIsZ9OgjsyZwCCw5Az05wPRdJ0Q0p1Tg=\" rel=\"nofollow\" target=\"_blank\">Events<\/a>\u201d page of the BBOT website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tirNbDiEeJPy2SZQjl7iCCaH5GlSvhQ-DKUfbyHpr5zMAEEv7DlzJNDusViPK3so_htYIhZELIr0R5JwvRwtsl1RMJG_578HEVivdLhxnUSairAQjjOTHGNwhw-GhHB_qBMsa5bztvf9g4GGFg0NXhtqdtqi_nVXa-Rwe8J_FB0=\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.bbotx.com\/news-events\/events<\/a>. A replay of the webcast will be available for at least 90 days following the event.<\/p>\n<p align=\"left\">\n        <strong>About BBOT<\/strong><br \/>\n        <br \/>BBOT is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3K\u03b1 malignancies. BBOT has the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jduE9_8LUGzR8HK-qG6nbY2ykzZp_jnIyNNMhNMzQ4_W7wj7H44SApFyxG_qew9Cxwejl46eJxm9Z4cNBsH1GA==\" rel=\"nofollow\" target=\"_blank\"><strong>www.bbotx.com<\/strong><\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1tfkXYaoCGrVZVouAyTzU83aWvVJ9eewMbd4yMOlbMqbcwl5clrqQEAi53bY96yyfBVkIQZ0wn6agvnotrzVtQci5sc4Gx0uZymVxwUjTT_2mTJCgwRiDiBnWp8BIcCY\" rel=\"nofollow\" target=\"_blank\"><strong>LinkedIn<\/strong><\/a>.<\/p>\n<p align=\"left\">\n        <strong>BBOT Contacts:<\/strong>\n      <\/p>\n<p align=\"left\">\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Heather Armstrong, Head of Investor Relations<br \/>BBOT<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IeMcBzCyTNOYDF9BblxFheqRrtHpyd2jQTrzEXCIdlrwFRi0rAJE9YC5X_UxuojiScnuB9dfMbkQ1I1T4NCVfD0ZwqV1fZk4SSeL6hgR2jE=\" rel=\"nofollow\" target=\"_blank\"><strong>Investors@BBOTx.com<\/strong><\/a><\/p>\n<p align=\"left\">\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Jake Robison<br \/>Inizio Evoke Comms<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=p1-EDxbTPGRU1MiR3pI1Go5BXD5OQjlkQ2q0Fttb3u1HvrB2fk_eefHs5QPJr6wtHjkBwWfOvisGWYZNiEtQZyCjOBHEf_1PvN98qt-DxW-xAy98ItMhYq-XpbJFq0NN\" rel=\"nofollow\" target=\"_blank\"><strong>Jake.robison@inizioevoke.com<\/strong><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzQyMCM3MjQwNDAyIzIzMDI0OTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OWQ2M2ExZmEtOTg5Mi00MzE4LWE0MzAtMGJlY2Y5MGU1NTQ0LTEzMTQwNDctMjAyNS0xMS0wMy1lbg==\/tiny\/TheRas-Inc-d-b-a-BridgeBio-Onc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; BridgeBio Oncology Therapeutics, Inc. (\u201cBBOT\u201d) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in a presentation at the Jefferies Global Healthcare Conference on Monday, November 17, at 2:30 p.m. GMT.\u00a0\u00a0 A live webcast of the presentation will be accessible on the \u201cEvents\u201d page of the BBOT website at https:\/\/investors.bbotx.com\/news-events\/events. A replay of the webcast will be available for at least 90 days following the event. About BBOT BBOT is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3K\u03b1 malignancies. BBOT has the goal of improving outcomes for patients with cancers &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BBOT to Participate in the Jefferies Global Healthcare Conference in London&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-904626","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BBOT to Participate in the Jefferies Global Healthcare Conference in London - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BBOT to Participate in the Jefferies Global Healthcare Conference in London - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; BridgeBio Oncology Therapeutics, Inc. (\u201cBBOT\u201d) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in a presentation at the Jefferies Global Healthcare Conference on Monday, November 17, at 2:30 p.m. GMT.\u00a0\u00a0 A live webcast of the presentation will be accessible on the \u201cEvents\u201d page of the BBOT website at https:\/\/investors.bbotx.com\/news-events\/events. A replay of the webcast will be available for at least 90 days following the event. About BBOT BBOT is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3K\u03b1 malignancies. BBOT has the goal of improving outcomes for patients with cancers &hellip; Continue reading &quot;BBOT to Participate in the Jefferies Global Healthcare Conference in London&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-03T23:19:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzQyMCM3MjQwNDAyIzIzMDI0OTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BBOT to Participate in the Jefferies Global Healthcare Conference in London\",\"datePublished\":\"2025-11-03T23:19:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\\\/\"},\"wordCount\":179,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzQyMCM3MjQwNDAyIzIzMDI0OTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\\\/\",\"name\":\"BBOT to Participate in the Jefferies Global Healthcare Conference in London - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzQyMCM3MjQwNDAyIzIzMDI0OTc=\",\"datePublished\":\"2025-11-03T23:19:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzQyMCM3MjQwNDAyIzIzMDI0OTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzQyMCM3MjQwNDAyIzIzMDI0OTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BBOT to Participate in the Jefferies Global Healthcare Conference in London\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BBOT to Participate in the Jefferies Global Healthcare Conference in London - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/","og_locale":"en_US","og_type":"article","og_title":"BBOT to Participate in the Jefferies Global Healthcare Conference in London - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; BridgeBio Oncology Therapeutics, Inc. (\u201cBBOT\u201d) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in a presentation at the Jefferies Global Healthcare Conference on Monday, November 17, at 2:30 p.m. GMT.\u00a0\u00a0 A live webcast of the presentation will be accessible on the \u201cEvents\u201d page of the BBOT website at https:\/\/investors.bbotx.com\/news-events\/events. A replay of the webcast will be available for at least 90 days following the event. About BBOT BBOT is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3K\u03b1 malignancies. BBOT has the goal of improving outcomes for patients with cancers &hellip; Continue reading \"BBOT to Participate in the Jefferies Global Healthcare Conference in London\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-03T23:19:56+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzQyMCM3MjQwNDAyIzIzMDI0OTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BBOT to Participate in the Jefferies Global Healthcare Conference in London","datePublished":"2025-11-03T23:19:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/"},"wordCount":179,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzQyMCM3MjQwNDAyIzIzMDI0OTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/","name":"BBOT to Participate in the Jefferies Global Healthcare Conference in London - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzQyMCM3MjQwNDAyIzIzMDI0OTc=","datePublished":"2025-11-03T23:19:56+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzQyMCM3MjQwNDAyIzIzMDI0OTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzQyMCM3MjQwNDAyIzIzMDI0OTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-the-jefferies-global-healthcare-conference-in-london\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BBOT to Participate in the Jefferies Global Healthcare Conference in London"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904626","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=904626"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904626\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=904626"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=904626"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=904626"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}